Nivolumab-induced posterior reversible encephalopathy syndrome.
作者信息
Hussein Haitham M, Dornfeld Bradleigh, Schneider Daniel J
机构信息
Regions Hospital Comprehensive Stroke Center (HMH), St Paul; Hennepin County Medical Center (BD), Minneapolis; and HealthPartners Clinics and Services (DJS), St Paul, MN.
出版信息
Neurol Clin Pract. 2017 Oct;7(5):455-456. doi: 10.1212/CPJ.0000000000000362.
Abstract
摘要
相似文献
1
Nivolumab-induced posterior reversible encephalopathy syndrome.
Neurol Clin Pract. 2017 Oct;7(5):455-456. doi: 10.1212/CPJ.0000000000000362.
2
Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome.
CEN Case Rep. 2015 Nov;4(2):190-195. doi: 10.1007/s13730-014-0165-7. Epub 2014 Dec 30.
3
Posterior reversible encephalopathy syndrome in eclampsia.
Neurol India. 2018 Sep-Oct;66(5):1316-1323. doi: 10.4103/0028-3886.241364.
4
Vinblastine-induced posterior reversible encephalopathy syndrome.
J Oncol Pharm Pract. 2019 Dec;25(8):2019-2022. doi: 10.1177/1078155218816776. Epub 2018 Dec 11.
5
Posterior reversible encephalopathy syndrome: incidence and associated factors in a pediatric critical care population.
Pediatr Neurol. 2013 Nov;49(5):335-9. doi: 10.1016/j.pediatrneurol.2013.06.007. Epub 2013 Aug 2.
6
Predisposing factors of posterior reversible encephalopathy syndrome in acute childhood leukemia.
Pediatr Neurol. 2012 Dec;47(6):436-42. doi: 10.1016/j.pediatrneurol.2012.07.011.
7
Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms.
Am J Obstet Gynecol. 2016 Aug;215(2):239.e1-5. doi: 10.1016/j.ajog.2016.02.039. Epub 2016 Feb 20.
8
Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
J Child Neurol. 2016 Mar;31(3):279-84. doi: 10.1177/0883073815589758. Epub 2015 Jun 9.
9
Posterior reversible encephalopathy syndrome associated with licorice consumption: a case report in a 10-year-old boy.
Pediatr Neurol. 2015 Apr;52(4):457-9. doi: 10.1016/j.pediatrneurol.2014.12.001. Epub 2014 Dec 11.
10
Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report.
J Med Case Rep. 2014 Dec 18;8:442. doi: 10.1186/1752-1947-8-442.
引用本文的文献
1
A Pressing Emergency in Oncology: A Case Series of Patients With Posterior Reversible Encephalopathy Syndrome.
Cureus. 2024 Dec 3;16(12):e75028. doi: 10.7759/cureus.75028. eCollection 2024 Dec.
2
Neuro-ophthalmic complications of modern anti-cancer drugs.
Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2269-2281. doi: 10.1007/s00417-023-06350-4. Epub 2024 Feb 12.
3
Nivolumab-Induced PRES (Posterior Reversible Encephalopathy Syndrome).
Cureus. 2023 Jun 16;15(6):e40533. doi: 10.7759/cureus.40533. eCollection 2023 Jun.
4
Evaluation and management of acute high-grade immunotherapy-related neurotoxicity.
Heliyon. 2023 Feb 14;9(3):e13725. doi: 10.1016/j.heliyon.2023.e13725. eCollection 2023 Mar.
5
Neurology of cancer immunotherapy.
Neurol Sci. 2023 Jan;44(1):137-148. doi: 10.1007/s10072-022-06297-0. Epub 2022 Sep 16.
6
Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development.
Clin Med Insights Oncol. 2021 Nov 24;15:11795549211056261. doi: 10.1177/11795549211056261. eCollection 2021.
7
Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small-cell lung cancer.
Clin Case Rep. 2019 Apr 1;7(5):935-938. doi: 10.1002/ccr3.2122. eCollection 2019 May.
8
Fatal Necrotizing Encephalopathy after Treatment with Nivolumab for Squamous Non-Small Cell Lung Cancer: Case Report and Review of the Literature.
Front Immunol. 2018 Jan 30;9:108. doi: 10.3389/fimmu.2018.00108. eCollection 2018.
本文引用的文献
1
Posterior reversible encephalopathy syndrome following pembrolizumab therapy for relapsed Hodgkin's lymphoma.
J Oncol Pharm Pract. 2017 Jan;23(1):71-74. doi: 10.1177/1078155215620922. Epub 2016 Jul 9.
2
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma.
J Clin Oncol. 2012 Feb 20;30(6):e76-8. doi: 10.1200/JCO.2011.38.7886. Epub 2011 Dec 27.
Zotero 插件